Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

By Bristow L.J.   Kramer M.S.   Kulagowski J.   Patel S.   Ragan C.I.   Seabrook G.R.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 186-188

Elsevier

Access to resources Recommend Favorite

Evidence for a G protein-coupled diadenosine-5',5&unknown;-P 1 ,P 4 -tetraphosphate (Ap 4 A) receptor binding site in lung membranes from rat

By Laubinger W.   Reiser G.  

European Journal of Pharmacology, Vol. 366, Iss. 1, 1999-01 ,pp. : 93-100

Elsevier

Access to resources Recommend Favorite

Dopamine D 4 receptor and anxiety: Behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze

By Cao B.-J.   Rodgers R.J.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 117-125

Elsevier

Access to resources Recommend Favorite

The dopamine D 4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline

By Costanza R.M.   Terry P.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

Chemogenomic Investigation of AP-1 Transcriptional Regulation of LTC4 Synthase Expression

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 3, 2004-07 ,pp. : 211-216

Bentham Science Publishers

Access to resources Recommend Favorite